{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:33:55Z","timestamp":1792186435846,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.virs.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T02:26:27Z","timestamp":1651458387000},"page":"531-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence"],"prefix":"10.1016","volume":"37","author":[{"given":"Xiaojing","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-8889","authenticated-orcid":false,"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.04.015_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41419-017-0195-0","article-title":"Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells","volume":"9","author":"Augello","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.virs.2022.04.015_bib2","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1111\/1469-0691.12291","article-title":"Hantavirus infections","volume":"21S","author":"Avsic-Zupanc","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virs.2022.04.015_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/095632020101200506","article-title":"Anti-HIV-1 activity and structure-activity relationship of cepharanoline derivatives in chronically infected cells","volume":"12","author":"Baba","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virs.2022.04.015_bib4","doi-asserted-by":"crossref","first-page":"152956","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: an update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.virs.2022.04.015_bib5","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.04.015_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/v11070610","article-title":"Progress on the prevention and treatment of hantavirus disease","volume":"11","author":"Brocato","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.04.015_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbrc.2017.10.037","article-title":"Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection","volume":"494","author":"Cho","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virs.2022.04.015_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.2002.1685","article-title":"Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA","volume":"304","author":"Diamond","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virs.2022.04.015_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-022-07329-w","article-title":"Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages","author":"Engur-Ozturk","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.virs.2022.04.015_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.345.6198.718","article-title":"Infectious diseases. Debate erupts on 'repurposed' drugs for Ebola","volume":"345","author":"Enserink","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.04.015_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248140","article-title":"Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening","volume":"16","author":"Grad","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2022.04.015_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13002-015-0019-1","article-title":"Ethnobotanical study on medicinal plants used by Maonan people in China","volume":"11","author":"Hong","year":"2015","journal-title":"J.\u00a0Ethnobiol. Ethnomed."},{"key":"10.1016\/j.virs.2022.04.015_bib13","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.935860","article-title":"Combined liver, pancreas-duodenum, and kidney transplantation for patients with hepatitis B cirrhosis, uremia, and insulin-dependent diabetes","volume":"27","author":"Hong","year":"2022","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.virs.2022.04.015_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/infdis\/153.3.489","article-title":"Ribavirin therapy for Hantaan virus infection in suckling mice","volume":"153","author":"Huggins","year":"1986","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.04.015_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/AAC.26.4.476","article-title":"Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses","volume":"26","author":"Huggins","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2022.04.015_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fphar.2019.01025","article-title":"Toosendanin from melia fructus suppresses influenza A virus infection by altering nuclear localization of viral polymerase PA protein","volume":"10","author":"Jin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virs.2022.04.015_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CMR.00062-09","article-title":"A\u00a0global perspective on hantavirus ecology, epidemiology, and disease","volume":"23","author":"Jonsson","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virs.2022.04.015_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cimid.2007.05.011","article-title":"Hantavirus infection in East Asia","volume":"30","author":"Kariwa","year":"2007","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virs.2022.04.015_bib19","first-page":"107","article-title":"Study on the inhibitory effect of cepharanthine on herpes simplex type-1 virus (HSV-1) in vitro","volume":"27","author":"Liu","year":"2004","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.virs.2022.04.015_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jmv.25054","article-title":"Hantavirus induced cardiopulmonary syndrome: a public health concern","volume":"90","author":"Llah","year":"2018","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.virs.2022.04.015_bib21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.bmcl.2014.03.041","article-title":"Cepharanthine inhibited HIV-1 cell-cell transmission and cell-free infection via modification of cell membrane fluidity","volume":"24","author":"Matsuda","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.virs.2022.04.015_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virs.2022.04.015_bib23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2022.04.015_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10393-017-1305-2","article-title":"Global diversity and distribution of hantaviruses and their hosts","volume":"15","author":"Milholland","year":"2018","journal-title":"EcoHealth"},{"key":"10.1016\/j.virs.2022.04.015_bib25","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/v6031274","article-title":"Recent evidence of hantavirus circulation in the American tropic","volume":"6","author":"Montoya-Ruiz","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.04.015_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12250-020-00237-y","article-title":"Monitoring neutralization property change of evolving hantaan and Seoul viruses with a novel pseudovirus-based assay","volume":"36","author":"Ning","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2022.04.015_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virs.2022.04.015_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jmgm.2017.04.005","article-title":"In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T315I mutant and wild-type BCR-ABL1: a virtual screening and molecular dynamics study","volume":"74","author":"Sohraby","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.virs.2022.04.015_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006901","article-title":"The ecological dynamics of hantavirus diseases: from environmental variability to disease prevention largely based on data from China","volume":"13","author":"Tian","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2022.04.015_bib30","doi-asserted-by":"crossref","first-page":"26456","DOI":"10.1038\/srep26456","article-title":"Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.04.015_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ekir.2021.12.005","article-title":"Long-term results of triple immunosuppression with tacrolimus added to mycophenolate and corticosteroids in the treatment of lupus nephritis","volume":"7","author":"Yap","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.virs.2022.04.015_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2012.06.009","article-title":"Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells","volume":"168","author":"Ye","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.virs.2022.04.015_bib33","first-page":"493","article-title":"Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro","volume":"118","author":"Zhang","year":"2005","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.virs.2022.04.015_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.virs.2022.04.015_bib35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/21645515.2017.1325050","article-title":"A\u00a0bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2022.04.015_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1745-7254.2006.00281.x","article-title":"High-throughput fluorescence polarization method for identifying ligands of LOX-1","volume":"27","author":"Zhang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.virs.2022.04.015_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2012.02.030","article-title":"In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates","volume":"683","author":"Zhou","year":"2012","journal-title":"Eur. J. Pharmacol."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:17:27Z","timestamp":1761851847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1995820X22000797"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.04.015","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and identification of HTNVpv entry inhibitors with high-throughput pseudovirus-based chemiluminescence","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}